🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Austria
Clinical trial register · Austria

Studies with an Austrian investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Austria and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1573 matching records held by the registry are in this view. Synced 26 Sep 2026, 19:45 UTC
1573
Studies in scope
all four open statuses
850
Recruiting now
open to new participants
339
Lead sponsors
across recruiting studies
Top sites
Vienna 1005 Graz 506 Linz 438 Innsbruck 398 Salzburg 291
Narrow the register
Recruitment status
Phase
Lead sponsor
Medical University of Vienna148 Medical University of Graz86 AstraZeneca54 Medical University Innsbruck42 Novartis Pharmaceuticals41
Site location
Vienna1005 Graz506 Linz438 Innsbruck398 Salzburg291
All 97 locations
Target enrolment
to

Trials in this register

1573 of 1573 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Austria
Start
Recruiting
Retrospective Register for Uveal Melanoma
NCT05733728Uveal Melanoma
Medical University of Vienna
Observational
1,400
Vienna
2023-01-23
Recruiting
Coagulation in Cirrhosis
NCT05667805Liver Cirrhosis
DrugProthrombin Complex
Medical University of Vienna
Phase 4
400
Vienna
2023-01-19
Active, closed
A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy
NCT05405361Multifocal Motor Neuropathy (MMN)
DrugEmpasiprubart
argenx
Phase 2
51
Vienna
2023-01-18
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Graz, Innsbruck, Salzburg, Sankt Veit an der Glan
2023-01-16
Recruiting
Quality of Life in Acute Complicated and Chronic Recurrent Left-sided Diverticulitis
NCT05942833Diverticulitis of Sigmoid
Kepler University Hospital
Not applicable
136
Linz
2023-01-16
Recruiting
Austrian Registry for Evaluation of Treatment Patterns and Outcome in Patients With Advanced Pancreatic Ductal Adenocarcinoma (PDAC)
NCT05526443Pancreatic Cancer, Advanced Pancreatic Carcinoma
Medical University of Graz
Observational
1,500
Graz, Linz, Amstetten, Feldkirch, Innsbruck, Klagenfurt, Salzburg, Sankt Pölten
2023-01-13
Active, closed
A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease
NCT05668013Crohn Disease, Colitis, Ulcerative
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
247
Vienna
2023-01-11
Active, closed
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
NCT05555732Metastatic Non Small Cell Lung Cancer
DrugsDatopotamab Deruxtecan·Keytruda·Pemetrexed·Cisplatin
Daiichi Sankyo
Phase 3
1,170
Feldkirch, Klagenfurt, Vienna
2023-01-11
Recruiting
Alleviant ALLAY-HF Study
NCT05685303Heart Failure
Alleviant Medical, Inc.
Not applicable
700
Graz
2023-01-10
Active, closed
A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
NCT05552976Relapsed or Refractory Multiple Myeloma
DrugsMezigdomide·Carfilzomib·Dexamethasone
Bristol-Myers Squibb
Phase 3
606
Vienna, Linz
2023-01-10
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
NCT05701917Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome
Inari Medical
Not applicable
300
Vienna
2023-01-06
Active, closed
Longitudinal Clinical Observation of a Digital Twin Model for Blastocyst Evaluation in IVF Clinics
NCT07305480Implantation, Embryo
Ukraine Association of Biobank
Observational
1
Graz
2023-01-02
Active, closed
Serratus Planus Block After Minimally Invasive Cardiac Surgery
NCT06746272Pain, Postoperative
Medical University of Vienna
Phase 4
66
Vienna
2023-01-01
Recruiting
ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank
NCT06162546Focal Segmental Glomerulosclerosis, Proteinuria, Nephrotic Syndrome, Nephrotic Syndrome Steroid-Resistant
Christoph Aufricht
Observational
100
Vienna
2023-01-01
By invitation
European TIF2.0 Registry
NCT07395219Gastro -Oesophagal Reflux, Laryngo-pharyngeal Reflux
Cleveland Clinic London
Observational
500
Vienna
2023-01-01
Recruiting
Risk of Recurrent CeAD After Pregnancy
NCT06258109Cervical Artery Dissection, Pregnancy Complications
University Hospital, Basel, Switzerland
Observational
1,000
Innsbruck
2023-01-01
Recruiting
Observational Study on "Functional Overlay" in Patients With Movement Disorders
NCT05943652Conversion Disorder, Parkinson Disease, Tremor, Dystonia
Medical University of Graz
Observational
216
Graz
2023-01-01
Recruiting
Mycobacteria Registry Study: Prospective Observational Study in Austria
NCT06522347Non-Tuberculous Mycobacterial Pneumonia, Tuberculosis
Ludwig Boltzmann Institute for Lung Health
Observational
1,000
Vienna
2023-01-01
Active, closed
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
NCT05595642Chronic Obstructive Pulmonary Disease (COPD)
DrugAstegolimab
Hoffmann-La Roche
Phase 3
1,290
Feldbach, Linz
2022-12-29
Active, closed
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
NCT05687266NSCLC
DrugsDatopotamab Deruxtecan·Durvalumab·Pemetrexed·Paclitaxel
AstraZeneca
Phase 3
1,350
Graz, Rankweil, Vienna
2022-12-29
By invitation
Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema
NCT05396105Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II
DrugDeucrictibant
Pharvaris Netherlands B.V.
Phase 2/3
150
Graz, Vienna
2022-12-28
Recruiting
European Myeloma Network (EMN) Sample Project
NCT06237803Multiple Myeloma, Smoldering Multiple Myeloma, Plasma Cell Leukemia, Extramedullary Myeloma
European Myeloma Network B.V.
Observational
6,000
Linz, Vienna
2022-12-21
Recruiting
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
NCT05549297Advanced Melanoma
DrugTebentafusp
Immunocore Ltd
Phase 3
540
Graz, Linz, Salzburg, Vienna
2022-12-19
Recruiting
SteamOne - Prospective Database for Rezum Water Vapor Therapy of the Prostate
NCT05495633Benign Prostate Obstruction (BPO)
University Hospital, Basel, Switzerland
Observational
1,000
Graz
2022-12-16
Recruiting
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
NCT05327894Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia
DrugBlinatumomab
Princess Maxima Center for Pediatric Oncology
Phase 3
160
Graz, Innsbruck, Salzburg, Vienna
2022-12-15
Active, closed
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
NCT05581303Atherosclerotic Cardiovascular Disease
DrugOlpasiran
Amgen
Phase 3
7,297
Feldkirch, Graz, Klagenfurt, Linz, Salzburg, Sankt Pölten, Vienna
2022-12-14
Active, closed
A Study of DZD9008 Versus Platinum-Based Doublet Chemotherapy in Local Advanced or Metastatic Non-small Cell Lung Cancer (WU-KONG28)
NCT05668988Non-small Cell Lung Cancer
DrugsSunvozertinib·Pemetrexed·Carboplatin
Dizal Pharmaceuticals
Phase 3
324
Linz, Salzburg
2022-12-13
Active, closed
Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19
NCT05619653COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular, Left Ventricular Dysfunction
DrugsLosartan·Prednisolone
Valentina Puentmann
Phase 3
279
Vienna
2022-12-12
Recruiting
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
NCT05611801Hemophilia A, Hemophilia B
DrugMarstacimab
Pfizer
Phase 3
100
Vienna
2022-12-09
Active, closed
Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)
NCT05501886Breast Cancer
DrugsGedatolisib·Alpelisib·Palbociclib·Fulvestrant
Celcuity Inc
Phase 3
701
Graz, Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna, Wels
2022-12-08
Active, closed
Study of Efficacy and Safety of JDQ443 Single-agent as First-line Treatment for Patients With Locally Advanced or Metastatic KRAS G12C- Mutated Non-small Cell Lung Cancer With a PD-L1 Expression < 1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation.
NCT05445843Locally Advanced or Metastatic KRAS G12C-mutated NSCLC With a PD-L1 Expression <1% or a PD-L1 Expression ≥ 1% and an STK11 Co-mutation
DrugJDQ443
Novartis Pharmaceuticals
Phase 2
95
Feldkirch, Wels
2022-12-06
Recruiting
Hydrogel Coating to Reduce Post-surgical Infection After Joint Arthroplasty
NCT05679232Arthritis, Traumatic Arthritis, Avascular Necrosis
Medacta International SA
Not applicable
56
Vienna
2022-12-06
Active, closed
SerUM Markers in MERkel Cell Carcinoma Patients: a Longitudinal moniTorIng Study for optiMization of European Guidelines
NCT04705389Merkel Cell Carcinoma
University Hospital, Tours
Not applicable
35
Vienna
2022-12-05
Active, closed
SELUTION4SFA Trial
NCT05132361Peripheral Arterial Disease, Superficial Femoral Artery Stenosis
M.A. Med Alliance S.A.
Not applicable
300
Graz
2022-12-01
Recruiting
Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People
NCT06675851Major Depressive Disorder (MDD)
DrugsCipralex·Escitalopram
Medical University of Vienna
Phase 4
120
Vienna
2022-12-01
Recruiting
Prediction of Antidepressant Effects of Electroconvulsive Therapy
NCT05630469Depressive Disorder, Major
Medical University of Vienna
Observational
30
Vienna
2022-12-01
By invitation
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
NCT05667493Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)
DrugEplontersen
Ionis Pharmaceuticals, Inc.
Phase 3
1,400
Graz, Innsbruck, Vienna
2022-11-30
Active, closed
Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del
NCT05331183Cystic Fibrosis
DrugsELX/TEZ/IVA·Ivacaftor·Elexacaftor/Tezacaftor/Ivacaftor
Vertex Pharmaceuticals Incorporated
Phase 3
297
Innsbruck
2022-11-23
Active, closed
Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis
NCT05556096Generalized Myasthenia Gravis
Alexion Pharmaceuticals, Inc.
Phase 3
260
Innsbruck, Wels
2022-11-21
Active, closed
A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC
NCT05611671Inflammatory Bowel Diseases, Colitis, Ulcerative
DrugZotemtegrast
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Phase 2
280
Linz, Salzburg, Vienna
2022-11-21
Active, closed
RESPONDER-HF Trial
NCT05425459Heart Failure, Heart Failure, Diastolic
Corvia Medical
Not applicable
750
Graz
2022-11-17
Active, closed
Nutrition and Movement to Improve Quality of Life With Knee Osteoarthritis
NCT05955300Osteo Arthritis Knee
St. Pölten University of Applied Sciences
Not applicable
60
Sankt Pölten
2022-11-11
Active, closed
Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis
NCT05583227Eosinophilic Esophagitis
DrugTezepelumab
AstraZeneca
Phase 3
368
Vienna, Wels
2022-11-10
Recruiting
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
NCT05623020Multiple Myeloma
DrugsElranatamab·Bortezomib·Daratumumab·Lenalidomide
Pfizer
Phase 3
1,060
Sankt Pölten, Vienna, Graz, Linz, Wels, Rankweil, Salzburg
2022-11-10
Recruiting
A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker Over 18 Months of Use in Children and Young Adults From 1 to 18 Years of Age With Chronic Kidney Disease and Proteinuria
NCT05457283Chronic Kidney Disease, Proteinuria, Children
DrugFinerenone
Bayer
Phase 3
100
Vienna, Graz, Innsbruck
2022-11-08
Active, closed
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
NCT05444257Cystic Fibrosis
DrugVX-121/TEZ/D-IVA
Vertex Pharmaceuticals Incorporated
Phase 3
822
Graz, Innsbruck, Salzburg, Vienna
2022-11-08
Active, closed
A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
NCT05490446Myelodysplastic Syndromes
DrugTebapivat
Agios Pharmaceuticals, Inc.
Phase 2
87
Linz
2022-11-07
Recruiting
Hemodynamics in Chronic Hemodialysis Patients Undergoing Isolated Ultrafiltration Compared to Conventional Hemodialysis
NCT05642156End Stage Kidney Disease
Medical University of Graz
Not applicable
32
Graz
2022-11-02
Recruiting
Comparison of Esketamine/Propofol and Methohexital Anesthesia for ECT
NCT05655754ECT, Depression
DrugKetofol
Medical University of Vienna
Phase 4
100
Vienna
2022-11-01
Recruiting
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
NCT04790253Limited Stage Small Cell Lung Cancer, Extensive-stage Small-cell Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Graz
2022-10-27
Recruiting
An Observational Study to Assess the Effectiveness and Safety of a Cemiplimab in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) in Routine Clinical Practice Settings in Europe
NCT05363319Non-small Cell Lung Cancer
DrugCemiplimab
Regeneron Pharmaceuticals
Observational
500
Klagenfurt, Salzburg
2022-10-26
Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
NCT05552222Multiple Myeloma
DrugsTalquetamab·Teclistamab·Daratumumab·Lenalidomide
Janssen Research & Development, LLC
Phase 3
1,590
Linz, Salzburg, Vienna
2022-10-25
Recruiting
The CATALINA Study
NCT05008081Chronic Obstructive Pulmonary Disease Exacerbation
Wim Janssens
Observational
1,000
Linz, Vienna
2022-10-25
Active, closed
Berotralstat Treatment in Children With Hereditary Angioedema
NCT05453968Hereditary Angioedema, Pediatric
DrugBerotralstat
BioCryst Pharmaceuticals
Phase 3
29
Vienna
2022-10-25
Recruiting
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
NCT05253651Colorectal Neoplasms
DrugsLevoleucovorin·Erbitux·Tucatinib·Herceptin
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
400
Wels, Salzburg, Vienna, Wiener Neustadt
2022-10-24
Active, closed
Study of Oral Upadacitinib to Assess Change in Disease Activity in Adult Participants With Ulcerative Colitis
NCT05496348Ulcerative Colitis
AbbVie
Observational
400
Vienna, Linz, Salzburg
2022-10-20
Active, closed
Biomarkers and Event Patterns of Vascular Disease in Hemodialysis
NCT07170761Vascular Disease, CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder
Medical University of Graz
Observational
475
Graz
2022-10-15
Active, closed
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer
NCT05587296Vasomotor Symptoms Caused by Adjuvant Endocrine Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast Cancer, Hot Flashes
Bayer
Phase 3
474
Vienna, Salzburg
2022-10-14
Active, closed
Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)
NCT05776459Hearing Loss, Sensorineural
DrugPrednisolone
AudioCure Pharma GmbH
Phase 2
210
Graz, Linz, Salzburg, Vienna
2022-10-13
Active, closed
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
NCT05502237Non-small Cell Lung Cancer
DrugsDomvanalimab·Zimberelimab·Keytruda·Nab-paclitaxel
Gilead Sciences
Phase 3
1,021
Linz, Vienna, Wels
2022-10-12
Recruiting
Long-term Safety and Efficacy of GBG Study Participants
NCT05739591Breast Cancer
GBG Forschungs GmbH
Observational
400
Innsbruck, Wels, Graz, Linz, Salzburg, Vienna
2022-10-12
Active, closed
Role of Metformin in Posterior Capsule Opacification
NCT07176338Cataract, Diabetes Mellitus Type 2
Vienna Institute for Research in Ocular Surgery
Not applicable
40
Vienna
2022-10-12
Active, closed
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity
NCT05556512Obesity, Overweight
DrugTirzepatide
Eli Lilly and Company
Phase 3
15,374
Feldkirch, Graz, Innsbruck, Vienna
2022-10-11
Active, closed
Study Investigating Patient-Reported Outcomes in Lower-risk MDS Patients
NCT05582902MDS, MDS/MPN
University of Leipzig
Observational
60
Innsbruck
2022-10-11
Recruiting
Met Non Small Cell Cancer Registry (MOMENT)
NCT05376891Cancer
EMD Serono Research & Development Institute, Inc.
Observational
700
Klagenfurt, Salzburg, Vienna
2022-10-04
Active, closed
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
NCT05514054Breast Neoplasms
DrugsImlunestrant·Tamoxifen·Exemestane·Anastrozole
Eli Lilly and Company
Phase 3
8,000
Graz, Salzburg, Schwaz, Vienna
2022-10-04
Recruiting
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
NCT05183035Acute Myeloid Leukemia
DrugsGemtuzumab Ozogamicin·Cytarabine·Azacitidine·Fludarabine
PedAL BCU, LLC
Phase 3
130
Vienna
2022-10-01
Recruiting
Ketamine in OCD: Efficacy and Effects on Stress and Cognition
NCT05577585Obsessive-Compulsive Disorder, Psychiatric Disorder
DrugMidazolam
Medical University of Vienna
Not applicable
60
Vienna
2022-10-01
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT05519085Relapsed or Refractory Multiple Myeloma
DrugsMezigdomide·Pomalidomide·Bortezomib·Dexamethasone
Celgene
Phase 3
810
Vienna, Krems, Leoben, Sankt Pölten
2022-09-20
Active, closed
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma
NCT05409066Follicular Lymphoma (FL)
DrugsEpcoritamab·Lenalidomide·Rituximab
Genmab
Phase 3
549
Sankt Pölten, Linz, Salzburg
2022-09-20
Active, closed
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
NCT05242484Colitis, Ulcerative
DrugsJNJ-78934804·Golimumab·Guselkumab
Janssen Research & Development, LLC
Phase 2
577
Salzburg, Vienna, Wels
2022-09-19
Recruiting
Phase III Study of Induction and Consolidation Chemotherapy With Venetoclax in Patients With Newly Diagnosed AML or MDS-EB-2
NCT04628026Acute Myeloid Leukemia
DrugVenetoclax
University of Ulm
Phase 3
650
Innsbruck, Linz, Rankweil, Salzburg, Vienna
2022-09-13
Active, closed
Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
NCT05399992Primary Hypercholesterolemia, Mixed Dyslipidemia
Novartis Pharmaceuticals
Observational
847
Feldkirch, Graz, Linz, Sankt Veit im Pongau, Vienna
2022-09-12
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
NCT05243797Multiple Myeloma
DrugsTeclistamab·Lenalidomide
European Myeloma Network B.V.
Phase 3
1,594
Feldkirch, Innsbruck, Krems, Linz, Salzburg, Vienna
2022-09-08
Active, closed
Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis
NCT05570058IPF, Fibrosis
Redx Pharma Ltd
Phase 2
48
Vienna
2022-09-08
Recruiting
Metabolomics Study on Postoperative Intensive Care Acquired Muscle Weakness
NCT03810768Metabolomics, Critical Care, Critical Illness, Critical Illness Myopathy
Technical University of Munich
Observational
20
Vienna
2022-09-02
Recruiting
Evaluating the Addition of Hemodiafiltration to EVLP - Impact on the Regeneration of Marginal Donor Lungs
NCT06082401Lung Diseases
Medical University of Vienna
Not applicable
30
Vienna
2022-09-01
Recruiting
Haemoadsorption During Heart Transplantation
NCT05270902Heart Transplantation
Medical University of Vienna
Not applicable
40
Vienna
2022-09-01
By invitation
Outcome of Patients With Severe Functional TR According to Medical, Transcatheter or Surgical Treatment
NCT05825898Tricuspid Regurgitation
Ottawa Heart Institute Research Corporation
Observational
3,500
Vienna
2022-09-01
Recruiting
Asciminib Roll-over Study
NCT04877522Chronic Myelogenous Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive
DrugsAsciminib single agent·ABL001·Bosutinib·Nilotinib
Novartis Pharmaceuticals
Phase 4
347
Graz, Vienna
2022-08-30
Recruiting
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
NCT05156983Coagulation Disorder
Takeda
Phase 3
440
Graz, Neunkirchen
2022-08-24
Recruiting
Influence of an Anti-osteoporotic Drug on Healing After Surgical Repair of Chronic Rotator Cuff Lesions of the Shoulder
NCT05677152Orthopedics, Traumatology
DrugAclasta
AUVA Traumazentrum Vienna Site UKH Meidling
Phase 2
80
Vienna
2022-08-22
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
NCT05489705Obstructive Hypertrophic Cardiomyopathy
DrugMavacamten
Bristol-Myers Squibb
Observational
1,700
Braunau am Inn, Graz, Innsbruck, Klagenfurt, Linz, Sankt Pölten, Vienna
2022-08-16
Active, closed
A Research Study to Compare Somapacitan Once a Week With Norditropin® Once a Day in Children Who Need Help to Grow
NCT05330325SGA, Turner Syndrome, Noonan Syndrome, ISS
DrugsNorditropin·Somapacitan
Novo Nordisk A/S
Phase 3
412
Linz, Dornbirn, Sankt Pölten, Vöcklabruck
2022-08-10
Recruiting
Fertility and the Microbiome
NCT05328999Subfertility, Asthenozoospermia
Medical University of Graz
Observational
300
Graz
2022-08-10
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer
NCT05254171Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV
DrugsNab-paclitaxel·Gemcitabine
Panbela Therapeutics, Inc.
Phase 2/3
600
Klagenfurt, Sankt Pölten, Linz, Steyr, Wels, Rankweil, Salzburg, Wein
2022-08-08
Recruiting
High Intensity PreHab Before Major Abdominal Surgery
NCT05355909Prehabilitation
Medical University Innsbruck
Not applicable
60
Innsbruck
2022-08-01
Recruiting
Infants With Severe Acute Respiratory Distress Syndrome: The Prone Trial
NCT05002478Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Surfactant Dysfunction, Infant
Medical University of Vienna
Not applicable
14
Vienna
2022-07-30
Recruiting
Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases
NCT05124236Brain Metastases, Adult
Susanne Rogers
Not applicable
200
Innsbruck
2022-07-29
Active, closed
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
NCT05382286Triple Negative Breast Cancer, PD-L1 Positive
DrugsAbraxane·Taxol·Sacituzumab Govitecan·Keytruda
Gilead Sciences
Phase 3
443
Innsbruck, Linz, Salzburg, Sankt Pölten, Vienna
2022-07-25
Active, closed
A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease
NCT05242471Crohn's Disease
DrugsJNJ-78934804·Golimumab·Guselkumab
Janssen Research & Development, LLC
Phase 2
703
Salzburg, Vienna, Wels
2022-07-22
Recruiting
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
NCT05254743Chronic Lymphocytic Leukemia, Leukemia, Lymphocytic, Leukemia, B-cell, Small Lymphocytic Lymphoma
DrugsPirtobrutinib·Ibrutinib
Loxo Oncology, Inc.
Phase 3
737
Vienna
2022-07-22
Recruiting
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)
NCT04165486Multiple System Atrophy
Ionis Pharmaceuticals, Inc.
Phase 1
40
Innsbruck
2022-07-21
Active, closed
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
NCT05382299Triple Negative Breast Cancer, PD-L1 Negative
DrugsAbraxane·Sacituzumab Govitecan·Nab-paclitaxel·Gemcitabine
Gilead Sciences
Phase 3
623
Innsbruck, Linz
2022-07-20
Active, closed
STAR-LIFE: a Post-market Registry on MINIject
NCT05269680Open Angle Glaucoma
iSTAR Medical
Observational
320
Graz, Salzburg, Vienna
2022-07-20
Active, closed
Safety and Pharmacokinetics Study of a Modified Tafasitamab IV Dosing Regimen Combined With Lenalidomide in R-R DLBCL Patients
NCT05222555Diffuse Large B Cell Lymphoma
DrugsTafasitamab·Lenalidomide
Incyte Corporation
Phase 1/2
53
Sankt Pölten, Wels, Salzburg
2022-07-19
Active, closed
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
NCT05352672Melanoma
DrugsFianlimab·Cemiplimab·Pembrolizumab
Regeneron Pharmaceuticals
Phase 3
1,546
Sankt Pölten, Graz, Innsbruck, Vienna
2022-07-14
Active, closed
Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)
NCT05263934Eosinophilic Granulomatosis With Polyangiitis
DrugsDepemokimab·Mepolizumab
GlaxoSmithKline
Phase 3
163
Graz
2022-07-14
Active, closed
A Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed ES-SCLC Patients in Combination With Carboplatin, Etoposide and Atezolizumab
NCT05142696Extensive Stage Small Cell Lung Cancer
Drugs[177Lu]Lu-DOTA-TATE·[68Ga]Ga-DOTA-TATE·Atezolizumab
Novartis Pharmaceuticals
Phase 1/2
55
Vienna
2022-07-13
Active, closed
HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy
NCT05338970Nonsquamous Non-small Cell Lung Cancer, EGFR L858R, EGFR Exon 19 Deletion
DrugPatritumab deruxtecan
Daiichi Sankyo
Phase 3
586
Feldkirch, Innsbruck, Klagenfurt, Vienna, Wels
2022-07-08
Rows per page Showing 901–1000 of 1573
Previous 8 9 10 11 12 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Austrian investigative site. Derived from ClinicalTrials.gov. Retrieved 28 September 2026. https://priyalifescience.com/clinical-trials-austria?page=10

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Austria and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,573 studies in total at the last sync on 26 Sep 2026, 19:45 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

How many clinical trials are recruiting in Austria?

850 of the 1,573 studies in this register are recruiting new participants as of the 26 Sep 2026, 19:45 UTC sync. A further 89 have not yet opened recruitment, 590 are active but closed to new participants, and 44 are enrolling by invitation only. Eligibility for any study is decided by its study team.

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Breast Cancer (24) Multiple Myeloma (18) Ulcerative Colitis (18) Heart Failure (16) Crohn's Disease (15) Coronary Artery Disease (14) Atrial Fibrillation (14) Chronic Lymphocytic Leukemia (13) Non-small Cell Lung Cancer (12) Obesity (11) Non-Small Cell Lung Cancer (11) Cataract (11) Acute Myeloid Leukemia (10) Carcinoma, Non-Small-Cell Lung (10) Pulmonary Hypertension (9)
→

Browse trials by site location

Vienna (1005) Graz (506) Linz (438) Innsbruck (398) Salzburg (291) Sankt Pölten (113) Wels (92) Klagenfurt (62) Feldkirch (49) Krems (34) Wiener Neustadt (33) Leoben (27) Rankweil (24) Braunau am Inn (17) Steyr (14)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.